tiprankstipranks
Trending News
More News >
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Hong Kong Market

Compare ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) vs. Competitors

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$6.15
HK$3.70B
-5.46
-12.21%
Ascletis Pharma, Inc.
HK$12.33
HK$13.69B
-48.42
240.74%
1 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$8.66B
-41.39
70.70%
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$17.42B
121.79
457.56%
CStone Pharmaceuticals
HK$5.34
HK$7.80B
-17.23
129.49%
Shandong Boan Biotechnology Company., Limited. Class H
HK$8.56
HK$5.18B
134.79
-4.25%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
4.53
-0.49
-9.76%
HK:1672
Ascletis Pharma, Inc.
13.80
9.79
244.14%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.66
1.77
61.25%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
43.88
35.97
454.74%
HK:2616
CStone Pharmaceuticals
5.37
3.14
140.81%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
8.33
-0.37
-4.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts